+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Medical Biomimetics Market by Type, by Application, and by Region - Global Forecast to 2023-2033

  • PDF Icon

    Report

  • 200 Pages
  • December 2022
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5703329
The medical biomimetics market size is estimated to be USD 29,589.5 million in 2022 and is expected to witness a CAGR of 6.98% during the forecast period 2023-2033. Rising government funding for biomimetics research and advancements of medical engineering and nanotechnology in healthcare are some of the factors projected to drive the market growth in near future. Furthermore, rising awareness and use of biomimetics and advancements in nanotechnology is expected to support the market growth. However, high price of medical biomimetics is predicted to limit market growth are expected to restrain the market growth.

Advancements in nanotechnology is projected to propel the market growth during the forecast period. Nanomaterials are appealing for use in biomedical applications and show great potential in synthetic biology medicine based on their biocompatibility, physical, and chemical properties. Nanomaterials have been functionalized and modified by cell membrane-derived elements to create biomimetic nanomaterials with improved biocompatibility, stability, targeting, and specificity as a result of the development of biomimetic functionalized nanotechnology.

Rising awareness and use of biomimetics is predicted to fuel the market growth during the forecast period. All countries would continue their efforts to promote organ donation, but it is also essential to discover other alternatives, including bioengineering. Products based on biomimetics are being developed by numerous businesses. For instance, CorNeat Vision created the patented CorNeat KPro implant, a synthetic cornea that provides a long-term medical remedy for blindness and corneal injuries. The device is on a 510K clearance and CE marking path, and it is anticipated that marketing approval will occur in late 2024.

Segmentation

By Type

The market is categorized into orthopedic, dental, cardiovascular, ophthalmology, and others. In 2022, the cardiovascular segment accounted for the highest revenue share due to the fact that CVD is the leading cause of death worldwide with 17.9 million deaths per year. Every year, more than 2.1 million people have CVD implants to extend their lives. In addition, during the projected period, the segment will benefit from the launch of technically advanced items supported by government funding. In order to grow human replacement tissues as next-generation implants for treating CVDs, LifeMatrix has created a unique bioengineering method. The proprietary LifeMatrix tissues can be produced as heart valves, blood vessels, and other cardiovascular components. The biomimetic device aids in reducing the risks connected with repeat major surgeries over the patient's lifetime. The orthopedic segment is anticipated to witness the fastest CAGR growth during the anticipated period. The segment is growing as a result of technological developments and the introduction of new items. For instance, Sparta Biomedical Inc. obtained the USFDA's Breakthrough Device Designation in March 2021 for its SBM-01 Biomimetic Implant.

By Application

The market is categorized into wound healing, drug delivery, tissue engineering, and others. In the global market, the wound healing segment accounted for the largest revenue share in 2022 owing to rising number of surgical cases and the global increase in the incidence of chronic diseases. Additionally, the market will expand due to certain demographic trends, such as an ageing population, an increase in diabetes and obesity, and a corresponding increase in sensitivity to chronic wounds. Around 2% of the country's population, or 6.9 million people, had chronic wounds in the United States in 2021. Additionally, the growing population of patients in need of better care places a significant financial burden on the healthcare system. The overall cost of treating chronic wounds is sharply rising, and the most recent predicted yearly cost in the United States surpasses USD 28 billion. The medical biomimetics market is expected to expand significantly in the drug delivery segment during the projected period. The shift in patient preferences toward the use of advanced medication administration systems, as well as increased research and development, can be attributed to this.

Regional Markets

In 2022, North America region accounted for the highest revenue in the medical biomimetics market and is expected to maintain its dominance during the forecast period. This is attributed to region's high levels of R&D activity, high adoption of cutting-edge technology, high disposable income, and the presence of major market participants in the area. The medical biomimetics market is anticipated to grow rapidly in the Asia Pacific region over the course of the forecast period due to the region's large patient population, growing awareness and acceptance of new technology, and increasing activities by government to promote the development of the biotechnology industry.

Competitor Insights

Some of the key players operating in the medical biomimetics market are Osteopore International Pte Ltd, LifeMatrix, NanoHive Medical LLC, Swedish Biomimetics 3000 ApS, Wright Medical, Biomimetics Technologies Inc, Abbott, CorNeat Vision, AVINENT Science and Technology, Veryan Medical, SynTouch Inc, Vandstrom, Inc., Keystone Dental Group, Curasan, Inc., and Zimmer Biomet.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

For instance, in February 2022, Accelus and NanoHive Medical, LLC, a leader in the development of 3D printed, biomimetic spinal interbody fusion devices, signed a distribution partnership. The arrangement supports in the growth of NanoHive Medical's interbody fusion device line made of Hive Soft Titanium in the United States.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including type and application from 2022 to 2033.

Segmentation: Medical Biomimetics Market Report 2022 - 2033

Type (Revenue, USD Million), 2022 - 2033

  • Orthopedic
  • Dental
  • Cardiovascular
  • Ophthalmology
  • Others

Application (Revenue, USD Million), 2022 - 2033

  • Wound Healing
  • Drug Delivery
  • Tissue Engineering
  • Others

By Region (Revenue, USD Million), 2022 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Framework
1.3.1. Research Models
1.3.1.1. Bottom-up Approach
1.3.1.2. Top-down Approach
1.3.1.3. Data Triangulation
1.3.2. Data Analysis
1.3.2.1. Data Validation
1.3.2.2. Market Size Estimation
1.3.2.3. Market Forecast Model
2. Introduction: Medical Biomimetics3. Executive Summary
4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.1.5. Driver 5
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.2.4. Restraint 4
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.3.4. Opportunity 4
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.4.4. Trend 4
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3
4.5.4. Challenge 4
5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. SWOT Analysis
6. COVID-19 Impact Analysis: Medical Biomimetics Market
7. Market Analysis by Type
7.1. Orthopedic
7.1.1. Orthopedic Market Forecast, 2022-2033 (USD Million)
7.2. Dental
7.2.1. Dental Market Forecast, 2022-2033 (USD Million)
7.3. Cardiovascular
7.3.1. Cardiovascular Market Forecast, 2022-2033 (USD Million)
7.4. Ophthalmology
7.4.1. Ophthalmology Market Forecast, 2022-2033 (USD Million)
7.5. Others
7.5.1. Others Market Forecast, 2022-2033 (USD Million)
8. Market Analysis by Application
8.1. Wound Healing
8.1.1. Wound Healing Market Forecast, 2022-2033 (USD Million)
8.2. Drug Delivery
8.2.1. Drug Delivery Market Forecast, 2022-2033 (USD Million)
8.3. Tissue Engineering
8.3.1. Tissue Engineering Market Forecast, 2022-2033 (USD Million)
8.4. Others
8.4.1. Others Market Forecast, 2022-2033 (USD Million)
8. Regional Market Analysis
8.1. Regional Market Trends
9. North America Medical Biomimetics Market
9.1. North America Medical Biomimetics Market
9.1.1. North America Market Size and Forecast, 2022-2033 (USD Million)
9.1.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
9.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
9.2. U. S. Medical Biomimetics Market
9.2.1. U. S. Market Size and Forecast, 2022-2033 (USD Million)
9.2.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
9.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
9.3. Canada Medical Biomimetics Market
9.3.1. Canada Market Size and Forecast, 2022-2033 (USD Million)
9.3.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
9.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10. Europe Medical Biomimetics Market
10.1. Europe Medical Biomimetics Market
10.1.1. Europe Market Size and Forecast, 2022-2033 (USD Million)
10.1.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.2. Germany Medical Biomimetics Market
10.2.1. Germany Market Size and Forecast, 2022-2033 (USD Million)
10.2.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.3. UK Medical Biomimetics Market
10.3.1. UK Market Size and Forecast, 2022-2033 (USD Million)
10.3.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.4. France Medical Biomimetics Market
10.4.1. France Market Size and Forecast, 2022-2033 (USD Million)
10.4.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.4.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.5. Spain Medical Biomimetics Market
10.5.1. Spain Market Size and Forecast, 2022-2033 (USD Million)
10.5.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.5.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.6. Italy Medical Biomimetics Market
10.6.1. Italy Market Size and Forecast, 2022-2033 (USD Million)
10.6.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.6.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.7. Rest of Europe Medical Biomimetics Market
10.7.1. Rest of Europe Market Size and Forecast, 2022-2033 (USD Million)
10.7.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.7.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11. Asia Pacific Medical Biomimetics Market
11.1. Asia Pacific Medical Biomimetics Market
11.1.1. Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
11.1.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.2. Japan Medical Biomimetics Market
11.2.1. Japan Market Size and Forecast, 2022-2033 (USD Million)
11.2.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.3. China Medical Biomimetics Market
11.3.1. China Market Size and Forecast, 2022-2033 (USD Million)
11.3.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.4. India Medical Biomimetics Market
11.4.1. India Market Size and Forecast, 2022-2033 (USD Million)
11.4.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.4.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.5. South Korea Medical Biomimetics Market
11.5.1. South Korea Market Size and Forecast, 2022-2033 (USD Million)
11.5.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.5.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.5.1.3. Market Size and Forecast by Device, 2022-2033 (USD Million)
11.6. Australia Medical Biomimetics Market
11.6.1. Australia Market Size and Forecast, 2022-2033 (USD Million)
11.6.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.6.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.7. Rest of Asia Pacific Medical Biomimetics Market
11.7.1. Rest of Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
11.7.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.7.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12. Latin America Medical Biomimetics Market
12.1. Latin America Medical Biomimetics Market
12.1.1. Latin America Market Size and Forecast, 2022-2033 (USD Million)
12.1.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
12.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.2. Brazil Medical Biomimetics Market
12.2.1. Brazil Market Size and Forecast, 2022-2033 (USD Million)
12.2.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
12.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.3. Mexico Medical Biomimetics Market
12.3.1. Mexico Market Size and Forecast, 2022-2033 (USD Million)
12.3.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
12.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.4. Argentina Medical Biomimetics Market
12.4.1. Argentina Market Size and Forecast, 2022-2033 (USD Million)
12.4.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
12.4.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.5. Rest of Latin America Medical Biomimetics Market
12.5.1. Rest of Latin America Market Size and Forecast, 2022-2033 (USD Million)
12.5.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
12.5.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13. MEA Medical Biomimetics Market
13.1. MEA Medical Biomimetics Market
13.1.1. MEA Market Size and Forecast, 2022-2033 (USD Million)
13.1.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
13.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.2. GCC Medical Biomimetics Market
13.2.1. GCC Market Size and Forecast, 2022-2033 (USD Million)
13.2.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
13.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.3. South Africa Medical Biomimetics Market
13.3.1. South Africa Market Size and Forecast, 2022-2033 (USD Million)
13.3.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
13.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.4. Rest of MEA Medical Biomimetics Market
13.4.1. Rest of MEA Market Size and Forecast, 2022-2033 (USD Million)
13.4.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
13.4.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
14. Competitor Analysis
14.1. Market Share Analysis, 2022
14.2. Major Recent Developments, 2019-2022
15. Company Profiles
15.1. Osteopore International Pte Ltd
15.1.1. Company Snapshot
15.1.2. Company Overview
15.1.3. Financials
15.1.4. Product Benchmarking
15.1.5. Recent Developments
15.2. LifeMatrix
15.2.1. Company Snapshot
15.2.2. Company Overview
15.2.3. Financials
15.2.4. Product Benchmarking
15.2.5. Recent Developments
15.3. NanoHive Medical LLC
15.3.1. Company Snapshot
15.3.2. Company Overview
15.3.3. Financials
15.3.4. Product Benchmarking
15.3.5. Recent Developments
15.4. Swedish Biomimetics 3000 ApS
15.4.1. Company Snapshot
15.4.2. Company Overview
15.4.3. Financials
15.4.4. Product Benchmarking
15.4.5. Recent Developments
15.5. Wright Medical
15.5.1. Company Snapshot
15.5.2. Company Overview
15.5.3. Financials
15.5.4. Product Benchmarking
15.5.5. Recent Developments
15.6. Biomimetics Technologies Inc
15.6.1. Company Snapshot
15.6.2. Company Overview
15.6.3. Financials
15.6.4. Product Benchmarking
15.6.5. Recent Developments
15.7. Abbott
15.7.1. Company Snapshot
15.7.2. Company Overview
15.7.3. Financials
15.7.4. Product Benchmarking
15.7.5. Recent Developments
15.8. CorNeat Vision
15.8.1. Company Snapshot
15.8.2. Company Overview
15.8.3. Financials
15.8.4. Product Benchmarking
15.8.5. Recent Developments
15.9. AVINENT Science and Technology
15.9.1. Company Snapshot
15.9.2. Company Overview
15.9.3. Financials
15.9.4. Product Benchmarking
15.9.5. Recent Developments
15.10. Veryan Medical
15.10.1. Company Snapshot
15.10.2. Company Overview
15.10.3. Financials
15.10.4. Product Benchmarking
15.10.5. Recent Developments
15.11. SynTouch Inc
15.11.1. Company Snapshot
15.11.2. Company Overview
15.11.3. Financials
15.11.4. Product Benchmarking
15.11.5. Recent Developments
15.12. Vandstrom, Inc.
15.12.1. Company Snapshot
15.12.2. Company Overview
15.12.3. Financials
15.12.4. Product Benchmarking
15.12.5. Recent Developments
15.13. Keystone Dental Group
15.13.1. Company Snapshot
15.13.2. Company Overview
15.13.3. Financials
15.13.4. Product Benchmarking
15.13.5. Recent Developments
15.14. Curasan, Inc.
15.14.1. Company Snapshot
15.14.2. Company Overview
15.14.3. Financials
15.14.4. Product Benchmarking
15.14.5. Recent Developments
15.15. Zimmer Biomet
15.15.1. Company Snapshot
15.15.2. Company Overview
15.15.3. Financials
15.15.4. Product Benchmarking
15.15.5. Recent Developments
15.16. Others Prominent Players
16. Conclusion & Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Osteopore International Pte Ltd
  • LifeMatrix
  • NanoHive Medical LLC
  • Swedish Biomimetics 3000 ApS
  • Wright Medical
  • Biomimetics Technologies Inc
  • Abbott
  • CorNeat Vision
  • AVINENT Science and Technology
  • Veryan Medical
  • SynTouch Inc
  • Vandstrom Inc.
  • Keystone Dental Group
  • Curasan Inc.
  • Zimmer Biomet